Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
With the in-depth and comprehensive study of bacteria and their related ecosystems in the human body, bacterial-based drug delivery system has become an emerging biomimetic platform that can retain the innate biological functions. Benefiting from its good biocompatibility and ideal targeting ability...
Main Authors: | Haojie Chen, Pengyu Lei, Hao Ji, Qinsi Yang, Bo Peng, Jiahui Ma, Yimeng Fang, Linkai Qu, Hua Li, Wei Wu, Libo Jin, Da Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006423000030 |
Similar Items
-
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda ALTUNTAŞ, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Inhibitory Effect of E. coli Nissle 1917 on Clinical and Standard Strains of Pseudomonas aeruginosa
by: Sheyda Damoogh, et al.
Published: (2021-01-01)